Varsha Shukla
Affiliations: | National Institutes of Health, Bethesda, MD |
Area:
NeurodegenerationGoogle:
"Varsha Shukla"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Binukumar BK, Skuntz S, Prochazkova M, et al. (2019) Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model. Human Molecular Genetics |
Shukla V, Seo J, Binukumar BK, et al. (2017) TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice. Journal of Alzheimer's Disease : Jad. 56: 335-349 |
Amin ND, Zheng Y, Bk B, et al. (2016) The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35. Molecular Biology of the Cell |
Binukumar BK, Pelech SL, Sutter C, et al. (2016) Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases. Journal of Alzheimer's Disease : Jad |
Zheng YL, Zhang X, Fu HX, et al. (2016) Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. Plos One. 11: e0160252 |
Binukumar BK, Shukla V, Amin ND, et al. (2015) Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein. Journal of Alzheimer's Disease : Jad |
Bk B, Shukla V, Amin ND, et al. (2015) Peptide (TFP5/TP5), derived from Cdk5 activator P35, provides neuroprotection in the MPTP model of Parkinson's disease. Molecular Biology of the Cell |
Binukumar BK, Zheng YL, Shukla V, et al. (2014) TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity. Journal of Alzheimer's Disease : Jad. 39: 899-909 |
Zheng YL, Li C, Hu YF, et al. (2013) Cdk5 inhibitory peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage. Plos One. 8: e63332 |
Binukumar BK, Shukla V, Amin ND, et al. (2013) Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration. Histochemistry and Cell Biology. 140: 23-32 |